Proveca
Halton
About Proveca
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $10.0M
- Last round: Series Unknown (Apr 2017)
- Website: proveca.com
- Phone: +441925607000
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/proveca-24546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.